欧州連合 - イタリア語 - EMA (European Medicines Agency)

eli lilly nederland b.v. - olanzapina pamoato - schizofrenia - psicolettici - il trattamento di mantenimento dei pazienti adulti con schizofrenia è sufficientemente stabilizzato durante il trattamento acuto con olanzapina orale.

欧州連合 - イタリア語 - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - artrite, reumatoide - immunosoppressori - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant può essere usato in monoterapia o in combinazione con metotrexato. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - fluoxetinum - capsula - fluoxetinum 20 mg ut fluoxetini hydrochloridum, maydis amylum, dimeticonum, matériel de la capsule: e 131, e 172 (flavum), e 171, aqua, gelatina, encre: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, kalii hydroxidum, pro capsula. - antidepressivi - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - olanzapinum - compresse rivestite con - olanzapinum 5 mg, lactosum monohydricum 156 mg, hydroxypropylcellulosum, crospovidonum, magnesio stearas, cellulosum microcristallinum, hypromellosum, pellicule: cera carnauba, hypromellosum, e 171, macrogola, polysorbatum 80, per compresso haze. - neuroleptique - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - olanzapinum - compresse rivestite con - olanzapinum 10 mg, lactosum monohydricum 312 mg, hydroxypropylcellulosum, crospovidonum, magnesio stearas, cellulosum microcristallinum, hypromellosum, pellicule: cera carnauba, hypromellosum, e 171, macrogola, polysorbatum 80, per compresso haze. - neuroleptique - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - olanzapinum - compresse rivestite con - olanzapinum 2.5 mg, lactosum monohydricum 102.15 mg, hydroxypropylcellulosum, crospovidonum, magnesio stearas, cellulosum microcristallinum, hypromellosum, pellicule: cera carnauba, hypromellosum, e 171, macrogola, polysorbatum 80, per compresso haze. - neuroleptique - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - olanzapinum - compresse rivestite con - olanzapinum 15 mg, lactosum monohydricum 178.2 mg, hydroxypropylcellulosum, crospovidonum, cellulosum microcristallinum, magnesio stearas, hypromellosum, pellicule: cera carnauba, lactosum monohydricum 4.9 mg, hypromellosum, e 171, triacetinum, e 132, per compresso haze. - neuroleptique - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - olanzapinum - orale compresse morbide - olanzapinum 5 mg, gelatina, mannitolum 4,5 mg, aspartamum 600 µg, propylis parahydroxybenzoas natricus 37.5 mg, e 219 113 µg, per compresso corrisp. sodio 19 µg. - neuroleptique - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - olanzapinum - orale compresse morbide - olanzapinum 10 mg, gelatina, mannitolum 6 mg, aspartamum 800 µg, propylis parahydroxybenzoas natricus 50 µg, e 219 150 µg, per compresso corrisp. sodio 26 µg. - neuroleptique - synthetika

スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - olanzapinum - orale compresse morbide - olanzapinum 15 mg, gelatina, mannitolum 9 mg, aspartamum 1,2 mg, propylis parahydroxybenzoas natricus 75 µg, e 219 225 µg, per compresso corrisp. sodio 38 µg. - neuroleptique - synthetika